CryoPort, Inc. CYRX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Life Sciences Products | $78.65M+3.8% | $75.77M0.0% | $75.77M+2.4% | $74.02M— | —— | |
| Life Sciences Services | $106.6M+4.4% | $102.15M+4.3% | $97.97M+4.5% | $93.75M— | —— | |
| Segment Reporting Other Item Amount by Business | ||||||
| Life Sciences Products | $5.86M+6.9% | $5.48M+5.0% | $5.22M+7.7% | $4.85M— | —— | |
| Life Sciences Services | $10.97M+5.8% | $10.37M-2.8% | $10.67M-15.6% | $12.63M— | —— | |
| Adjusted Earnings Before Interest Tax Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $14.46M+1.1% | $14.31M-6.2% | $15.25M+4.6% | $14.58M— | —— | |
| Life Sciences Services | $1.17M+196% | -$1.22M+58.0% | -$2.9M+52.1% | -$6.06M— | —— | |
| Research And Development Expense Excluding Compensation And Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $2.45M+4.3% | $2.35M+1.6% | $2.31M+12.4% | $2.06M— | —— | |
| Life Sciences Services | $2.74M-22.2% | $3.52M-3.0% | $3.63M-8.8% | $3.98M— | —— | |
| Cost Of Goods And Services Sold Excluding Rent Compensation And Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $32.26M+5.7% | $30.52M+0.3% | $30.43M+1.1% | $30.11M— | —— | |
| Life Sciences Services | $28.68M+1.4% | $28.29M+4.6% | $27.04M+4.1% | $25.97M— | —— | |
| Rent Expenses by Business | ||||||
| Life Sciences Products | $756K-1.2% | $765K+1.9% | $751K-0.9% | $758K— | —— | |
| Life Sciences Services | $7.69M+0.6% | $7.64M+6.7% | $7.16M+13.7% | $6.3M— | —— | |
| Labor And Related Expense by Business | ||||||
| Life Sciences Products | $22.86M+2.3% | $22.34M+2.5% | $21.8M+0.6% | $21.68M— | —— | |
| Life Sciences Services | $55.36M+3.4% | $53.55M+2.2% | $52.37M+2.8% | $50.92M— | —— | |
| Cost Of Revenue by Product | ||||||
| Product | $45.35M+3.8% | $43.69M-0.2% | $43.79M+1.5% | $43.14M+0.8% | $42.81M-1.7% | |
| Service | $51.26M+3.7% | $49.43M+3.9% | $47.56M+3.0% | $46.18M+3.8% | $44.47M+2.1% | |
| Revenue by Product | ||||||
| Biologistics Solutions | $81.28M+4.0% | $78.14M+3.8% | $75.31M+3.4% | $72.84M+4.7% | $69.59M+3.8% | |
| Biostorage Bioservices | $19.26M+4.9% | $18.36M+4.0% | $17.66M+5.1% | $16.8M+6.1% | $15.83M+5.4% | |
| Revenue by Geography | ||||||
| Americas | $134.02M+2.1% | $131.26M+2.4% | $128.17M+4.3% | $122.87M+3.2% | $119.05M+4.8% | |
| Asia Pacific | $20.41M+3.2% | $19.78M+3.7% | $19.08M+1.0% | $18.89M+16.2% | $16.27M+0.4% | |
| EMEA | $28.51M+13.4% | $25.13M+0.8% | $24.93M+1.8% | $24.5M-2.8% | $25.2M-6.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CryoPort, Inc. break its business down?
- CryoPort, Inc. (CYRX) reports revenue by business across 2 parts — Life Sciences Products and Life Sciences Services. Each is extracted from the segment footnotes and tracked over time.
- Where does CryoPort, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CryoPort, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
